Raj C Shah Selected Research

Raj C Shah Research Topics

Disease

29	Dementia (Dementias) 12/2023 - 02/2016
13	Cognitive Dysfunction 11/2023 - 01/2006
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 10/2017
8	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 01/2014
7	Neoplasms (Cancer) 12/2023 - 01/2017
4	Hemorrhage 01/2023 - 10/2018
3	Stroke (Strokes) 04/2024 - 03/2016
3	Frailty 10/2022 - 01/2022
3	Genetic Risk Score 01/2022 - 01/2021
3	Hypertension (High Blood Pressure) 11/2020 - 03/2016
3	Hippocampal Sclerosis 12/2019 - 02/2016
3	Infarction (Infarctions) 01/2019 - 01/2012
2	Chronic Renal Insufficiency 04/2024 - 01/2021
2	Infections 04/2024 - 01/2018
2	Myocardial Infarction 04/2024 - 03/2016
2	Inflammation (Inflammations) 10/2022 - 01/2021
2	Chronic Disease (Chronic Diseases) 01/2018 - 01/2018
1	Type 2 Diabetes Mellitus (MODY) 04/2024
1	Prediabetic State (Prediabetes) 01/2023
1	Ischemic Stroke 01/2023
1	Hemorrhagic Stroke 01/2023
1	Critical Illness (Critically Ill) 11/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Obesity 01/2020
1	Osteoarthritis 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Disease Progression 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Cerebral Infarction 12/2019
1	Secondary Parkinson Disease (Secondary Parkinsonism) 10/2019
1	Morbid Obesity 01/2019
1	Heart Failure 03/2016
1	Intermittent Claudication 03/2016
1	Pain (Aches) 09/2010
1	Human Influenza (Influenza) 10/2006

Drug/Important Bio-Agent (IBA)

25	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2024 - 10/2017
5	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2006
4	Apolipoproteins E (ApoE)IBA 05/2023 - 01/2021
4	Amyloid (Amyloid Fibrils)IBA 12/2019 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2023
2	ApolipoproteinsIBA 05/2023 - 01/2021
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2022 - 01/2013
2	Antidepressive Agents (Antidepressants)IBA 01/2019 - 02/2016
1	empagliflozinIBA 04/2024
1	SodiumIBA 04/2024
1	LipidsIBA 12/2023
1	oxidized low density lipoproteinIBA 12/2023
1	Triglycerides (Triacylglycerol)IBA 11/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Atorvastatin (Lipitor)FDA Link 01/2023
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2019
1	Memantine (Namenda)FDA Link 10/2019
1	Rivastigmine (Exelon)FDA LinkGeneric 10/2019
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2019
1	Donepezil (Aricept)FDA LinkGeneric 10/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	VaccinesIBA 01/2018
1	Amyloid beta-PeptidesIBA 02/2016
1	VitaminsIBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	SeleniumIBA 01/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2015
1	UridineIBA 01/2015
1	Eicosapentaenoic AcidIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2015
1	Docosahexaenoic AcidsIBA 01/2015
1	MicronutrientsIBA 01/2015
1	MSDC-0160IBA 01/2014
1	Insulin (Novolin)FDA Link 01/2014
1	Hemoglobins (Hemoglobin)IBA 01/2012
1	AdamantaneIBA 10/2006

Therapy/Procedure

4	Activities of Daily Living (ADL) 01/2022 - 09/2010
3	Therapeutics 01/2023 - 10/2019
2	Secondary Prevention 01/2023 - 01/2020
2	Polypharmacy 07/2022 - 01/2020
2	Terminal Care (Care, Terminal) 01/2020 - 01/2018
1	Artificial Respiration (Mechanical Ventilation) 11/2020
1	Hospice Care (Care, Bereavement) 01/2020
1	Contraindications 10/2017